Regeneron Pharmaceuticals (REGN)
Working Capital Ratio
30.95%
Quarterly · Period ending:
REGN Working Capital Ratio
Latest reported30.95%period ending
Latest reported30.95%period ending
REGN Quarterly Working Capital Ratio (81.10% → 30.95%)
Quarterly working capital ratio
High-resolution chart · PNG
REGN working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 30.9499% | |
| 32.0575% | |
| 33.6636% | |
| 33.7461% | |
| 34.518% | |
| 37.302% | |
| 38.9747% | |
| 41.8585% | |
| 43.1543% | |
| 44.4887% | |
| 48.536% | |
| 46.7496% | |
| 45.0741% | |
| 45.9386% | |
| 43.6181% | |
| 45.341% | |
| 45.9314% | |
| 42.8803% | |
| 39.6402% | |
| 42.5009% | |
| 44.7047% | |
| 38.4719% | |
| 41.2607% | |
| 42.0281% | |
| 28.8162% | |
| 41.8144% | |
| 37.7739% | |
| 38.3355% | |
| 37.4833% | |
| 42.1415% | |
| 55.5328% | |
| 39.8159% | |
| 53.9072% | |
| 34.9845% | |
| 50.9005% | |
| 34.4448% | |
| 34.9236% | |
| 30.2019% | |
| 38.3228% | |
| 37.207% | |
| 36.3851% | |
| 37.4912% | |
| 45.8644% | |
| 37.4432% | |
| 37.1507% | |
| 42.2663% | |
| 47.8388% | |
| 47.8767% | |
| 45.3438% | |
| 48.0304% | |
| 66.1933% | |
| 51.7128% | |
| 57.0821% | |
| 48.7645% | |
| 70.043% | |
| 46.3705% | |
| 40.204% | |
| 39.7382% | |
| 38.1241% | |
| 21.0204% | |
| 26.4987% | |
| 54.3135% | |
| 56.0838% | |
| 46.8878% | |
| 37.7136% | |
| 37.0131% | |
| 44.7831% | |
| 46.8112% | |
| 54.6895% | |
| 55.8653% | |
| 65.3351% | |
| 60.2705% | |
| 60.9093% | |
| 53.8795% | |
| 54.917% | |
| 56.7678% | |
| 65.5925% | |
| 67.4323% | |
| 72.6333% | |
| 67.8661% | |
| 68.6032% | |
| 71.1236% | |
| 71.0825% | |
| 69.5097% | |
| 73.6916% | |
| 72.2791% | |
| 65.4853% | |
| 58.2498% | |
| 70.8678% | |
| 70.3209% | |
| 51.5653% | |
| 69.8584% | |
| 62.2141% | |
| 62.8133% | |
| 60.4815% | |
| 67.1702% | |
| 65.4393% | |
| 66.5813% | |
| 75.1244% | |
| 74.7967% |